658 related articles for article (PubMed ID: 12474233)
1. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
[TBL] [Abstract][Full Text] [Related]
4. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
5. Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN.
Jackson M; Howie SE; Weller R; Sabin E; Hunter JA; McKenzie RC
FASEB J; 1999 Mar; 13(3):495-502. PubMed ID: 10064616
[TBL] [Abstract][Full Text] [Related]
6. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
7. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the 230-kDa bullous pemphigoid antigen gene expression by interferon regulatory factor 1 and interferon regulatory factor 2 in normal human epidermal keratinocytes.
Odanagi M; Kikuchi Y; Yamazaki T; Kaneko T; Nakano H; Tamai K; Uitto J; Hanada K
Exp Dermatol; 2004 Dec; 13(12):773-9. PubMed ID: 15560761
[TBL] [Abstract][Full Text] [Related]
9. The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis.
Werner S; Beer HD; Mauch C; Lüscher B; Werner S
Oncogene; 2001 Nov; 20(51):7494-504. PubMed ID: 11709721
[TBL] [Abstract][Full Text] [Related]
10. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
[TBL] [Abstract][Full Text] [Related]
11. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.
Matsuyama T; Kimura T; Kitagawa M; Pfeffer K; Kawakami T; Watanabe N; Kündig TM; Amakawa R; Kishihara K; Wakeham A
Cell; 1993 Oct; 75(1):83-97. PubMed ID: 8402903
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet light suppresses IFN-gamma-induced IL-7 gene expression in murine keratinocytes by interfering with IFN regulatory factors.
Aragane Y; Schwarz A; Luger TA; Ariizumi K; Takashima A; Schwarz T
J Immunol; 1997 Jun; 158(11):5393-9. PubMed ID: 9164960
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of interferon regulatory factor-1 in the mucosa of children with celiac disease.
Salvati VM; MacDonald TT; del Vecchio Blanco G; Mazzarella G; Monteleone I; Vavassori P; Auricchio S; Pallone F; Troncone R; Monteleone G
Pediatr Res; 2003 Sep; 54(3):312-8. PubMed ID: 12788988
[TBL] [Abstract][Full Text] [Related]
14. The helix-loop-helix transcription factor Id1 is highly expressed in psoriatic involved skin.
Björntorp E; Parsa R; Thornemo M; Wennberg AM; Lindahl A
Acta Derm Venereol; 2003; 83(6):403-9. PubMed ID: 14690332
[TBL] [Abstract][Full Text] [Related]
15. IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
Yim JH; Wu SJ; Casey MJ; Norton JA; Doherty GM
J Immunol; 1997 Feb; 158(3):1284-92. PubMed ID: 9013971
[TBL] [Abstract][Full Text] [Related]
16. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
Wei L; Debets R; Hegmans JJ; Benner R; Prens EP
J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092
[TBL] [Abstract][Full Text] [Related]
17. Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.
Xi H; Eason DD; Ghosh D; Dovhey S; Wright KL; Blanck G
Oncogene; 1999 Oct; 18(43):5889-903. PubMed ID: 10557076
[TBL] [Abstract][Full Text] [Related]
18. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
Grieder FB; Vogel SN
Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
[TBL] [Abstract][Full Text] [Related]
19. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
[TBL] [Abstract][Full Text] [Related]
20. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Invest Dermatol; 2004 Jan; 122(1):51-60. PubMed ID: 14962089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
